CRCD2

CAS No. 941185-83-7

CRCD2( —— )

Catalog No. M36926 CAS No. 941185-83-7

1H-Benzimidazole-6-carboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]- may have antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 164 In Stock
10MG 265 In Stock
25MG 531 In Stock
50MG 807 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CRCD2
  • Note
    Research use only, not for human use.
  • Brief Description
    1H-Benzimidazole-6-carboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]- may have antitumor activity.
  • Description
    1H-Benzimidazole-6-carboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]- may have antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    941185-83-7
  • Formula Weight
    340.4
  • Molecular Formula
    C17H16N4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N)(=O)C=1C2=C(SC1NC(=O)C=3C=C4C(=CC3)N=CN4)CCCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Methyl 4-bromopyrrol...

    Methyl 4-bromopyrrole-2-carboxylate is a marine derived natural products found in Lissodendoryx sp.

  • Gly-Gly-Gly|H-Gly-Gl...

    H-Gly-Gly-Gly-OH (Standard) is the analytical standard of H-Gly-Gly-Gly-OH. This product is intended for research and analytical applications. H-Gly-Gly-Gly-OH, also known as Triglycine, is a tripeptide composed of glycine, glycine and glycine, which are linked by peptide bonds. Often used as a model compound in the study of protein structure and function. Glycylglycylglycine also acts as a neurotransmitter in the central nervous system and has been shown to have antioxidant properties. Furthermore, it may have potential research roles in various diseases such as cancer, diabetes and neurodegenerative diseases.

  • AZD-26

    AZD-26 is an allosteric AKT inhibitor (IC50: 1.04 μM).